Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Ann Thorac Surg. 2020 Oct 13;112(1):206–213. doi: 10.1016/j.athoracsur.2020.07.060

Table 2.

Generalized linear regression model for overall cost of hospitalization.

Percent change (95% CI) P value
Nighttime −4.5% (−12.7%–4.7%) 0.324
Recipient age (per year) −0.2% (−0.6%–0.2%) 0.246
Male recipient −6.9% (−14.0%-0.7%) 0.076
LAS (per unit) 0.8% (0.5%–1.1%) <0.001
Diagnosis
 Obstructive lung disease Reference
 Pulmonary vascular disease 49.5% (13.0%–102.1%) 0.007
 Cystic fibrosis −3.8% (−18.0%–12.9%) 0.633
 Restrictive lung disease 3.0% (−6.8%–13.8%) 0.566
Hypertension 8.3% (−0.5%–18.1%) 0.068
Preoperative ECMO/MV 19.9% (4.0%–38.9%) 0.013
Prior CT surgery 5.7% (−2.9%–15.1%) 0.201
CAD 9.3% (−2.0%–22.2%) 0.113
Single lung transplant 6.0% (−14.8%-34.0%) 0.614
Distant donor 8.6% (0.0%–17.9%) 0.051

Abbreviations: CAD, coronary artery disease; CI, confidence interval; CT, cardiothoracic surgery; ECMO, extracorporeal membrane oxygenation; LAS, lung allocation score; MV, mechanical ventilation.